Research area
Health & Longevity
Human health, disease, treatment and aging. The largest corpus area supports distinct cancer, neurological and therapeutic navigation.
-
Evidence date ·
How aging changes lung defenses and the prevention of severe infection
Review or Meta-AnalysisA review explains how aging changes lung defenses, why adapted vaccines can help, and what biomarkers and mouse studies can tell us about infection risk.
-
Evidence date ·
A gel combines structural support and drug delivery in injured rat spinal cords
Peer-Reviewed PaperHow an experimental gel re-forms, releases curcumin and supports nerve insulation—and what movement tests in rats reveal about spinal cord repair.
-
Evidence date ·
Bringing digital care tools together around older people’s needs
Clinical TrialExplore a 2022 proposal to connect digital tools for early detection and care, and why its ambitions do not establish benefits for older people.
-
Evidence date ·
How brain changes help explain differences in Alzheimer’s symptoms
Review or Meta-AnalysisExplore what Alzheimer's tests detect, how brain changes relate to symptoms, and why matching treatments to disease profiles still needs validation.
-
Evidence date ·
What engineered immune cells recognize in cells that stop dividing
Review or Meta-AnalysisEngineered T cells can kill senescent cells in culture, but benefits for age-associated disease remain unproven in people.
-
Evidence date ·
Why cells left in growth arrest after cancer therapy may become treatment targets
Review or Meta-AnalysisA review of 36 animal studies explains how targeting cells left after cancer therapy affects tumor size and survival—and why some combinations fail.
-
Evidence date ·
How tumors leave immune cells less able to fight and multiply
Review or Meta-AnalysisA review examines why restoring exhausted T cells may not be enough to sustain attacks on cancer, and why targeting senescent cells still needs clinical testing.
-
Evidence date ·
How transplantation can change a child’s immune defenses and later cancer vulnerability
Review or Meta-AnalysisA review explores how immune defenses rebuild after transplantation, what cancer figures mean, and what would make immune testing useful for safer care.
-
Evidence date ·
A planned study links device readings with brain scans and morning cognition
Clinical TrialA registered study plans to compare sleep and wake device readings with brain scans, blood biomarkers and morning cognition. Each comparison asks a different question.
-
Evidence date ·
Testing creatine during breast cancer chemotherapy and a year of recovery
Clinical TrialA planned trial in early-stage breast cancer explores creatine during chemotherapy and recovery. Learn why patient reports and cognitive tests both matter.










